These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2837097)

  • 1. Small intestine as possible source of increased plasma cGMP after administration of alpha-hANP to dogs.
    Ito K; Yukimura T; Takenaga T; Yamamoto K; Kangawa K; Matsuo H
    Am J Physiol; 1988 Jun; 254(6 Pt 1):G814-8. PubMed ID: 2837097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular, renal and endocrine effects of alpha-human atrial natriuretic peptide in patients with Cushing's syndrome and primary aldosteronism.
    Fujio N; Ohashi M; Nawata H; Kato K; Matsuo H; Ibayashi H
    J Hypertens; 1989 Aug; 7(8):653-9. PubMed ID: 2553806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sources of cyclic nucleotides in plasma.
    Wehmann RE; Blonde L; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):173-9. PubMed ID: 4357611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.
    Fujita T; Ito Y; Noda H; Sato Y; Ando K; Kangawa K; Matsuo H
    J Clin Invest; 1987 Sep; 80(3):832-40. PubMed ID: 3040808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide and urinary cyclic guanosine monophosphate in patients with chronic heart failure.
    Abraham WT; Hensen J; Kim JK; Dürr J; Lesnefsky EJ; Groves BM; Schrier RW
    J Am Soc Nephrol; 1992 Jun; 2(12):1697-703. PubMed ID: 1323337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of a synthetic alpha-human atrial natriuretic polypeptide (alpha-hANP) in anesthetized dogs.
    Yukimura T; Ito K; Takenaga T; Yamamoto K; Kangawa K; Matsuo H
    Eur J Pharmacol; 1984 Aug; 103(3-4):363-6. PubMed ID: 6237925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of alpha-human atrial natriuretic polypeptide (alpha-hANP) on chemical-induced pulmonary edema.
    Imamura T; Ohnuma N; Iwasa F; Furuya M; Hayashi Y; Inomata N; Ishihara T; Noguchi T
    Life Sci; 1988; 42(4):403-14. PubMed ID: 2828791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of alpha-human atrial natriuretic polypeptide and cyclic GMP in patients with heart disease.
    Hirata Y; Ishii M; Matsuoka H; Sugimoto T; Iizuka M; Uchida Y; Serizawa T; Sato H; Kohmoto O; Mochizuki T
    Am Heart J; 1987 Jun; 113(6):1463-9. PubMed ID: 3035910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of alpha-human atrial natriuretic peptide (alpha-hANP) analogs: role of charged groups in alpha-hANP.
    Minamitake Y; Kitajima Y; Furuya M; Yoshida M; Tanaka S
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2005-8. PubMed ID: 1665757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
    Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of synthetic human atrial natriuretic peptide (hANP) in conscious dogs.
    Johannessen AC; Schütten HJ; Torp-Pedersen C; Warberg J; Bie P
    Acta Physiol Scand; 1986 Aug; 127(4):449-54. PubMed ID: 2944353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for lack of a role of cGMP in effect of alpha-hANP on aldosterone inhibition.
    Matsuoka H; Ishii M; Hirata Y; Atarashi K; Sugimoto T; Kangawa K; Matsuo H
    Am J Physiol; 1987 May; 252(5 Pt 1):E643-7. PubMed ID: 3034071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-human atrial natriuretic polypeptide reduces the plasma arginine vasopressin concentration in human subjects.
    Fujio N; Ohashi M; Nawata H; Kato K; Ibayashi H; Kangawa K; Matsuo H
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):181-7. PubMed ID: 3024877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs.
    Bie P; Wang BC; Leadley RJ; Goetz KL
    Am J Physiol; 1988 Feb; 254(2 Pt 2):R161-9. PubMed ID: 2964204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANF-mediated renal cGMP generation in congestive heart failure.
    Margulies KB; Heublein DM; Perrella MA; Burnett JC
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F562-8. PubMed ID: 1849364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
    Blonde L; Wehmann RE; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of human atrial natriuretic peptide on renal function and vasopressin release.
    Kimura T; Abe K; Shoji M; Tsunoda K; Matsui K; Ota K; Inoue M; Yasujima M; Yoshinaga K
    Am J Physiol; 1986 May; 250(5 Pt 2):R789-94. PubMed ID: 2939732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentobarbital anesthesia alters renal actions of alpha-hANP in dogs.
    Madwed JB; Wang BC
    Am J Physiol; 1990 Mar; 258(3 Pt 2):R616-23. PubMed ID: 2138425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in exercise-induced left ventricular dysfunction by infusion of alpha-human atrial natriuretic peptide in coronary artery disease.
    Ukai M; Nishinaka Y; Sobue T; Miyahara T; Yokota M
    Am J Cardiol; 1995 Mar; 75(7):449-54. PubMed ID: 7863987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.